보조생식기술(ART) 시장 : 제품 유형별, 기술별, 시술별, 최종사용자별, 지역별

Assistive Reproductive Technology Market is estimated to be valued at USD 35,700 Mn in 2026 and is expected to reach USD 51,200 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033.

Assistive reproductive technology (ART) is an infertility treatment procedure. In this procedure, the sperm and eggs are taken out of the body and oocyte fertilization is done under laboratory environment. The fertilization process carried outside the body is known as In vitro fertilization (IVF). There are mainly two type of IVF procedures such IVF with Intracytoplasmic Sperm Injection (ICSI) and IVF without Intracytoplasmic Sperm Injection (ICSI).

Market Dynamics

Increase in infertility rates over the past years has supported growth of global assistive reproductive technologies market growth. For instance, according to the European society of Human Reproduction and Embryology (ESHRE) in 2018, more than 8 million babies, were born from IVF procedure. This rising number of IVF procedures is expected to boost the global assistive reproductive technology market growth.

Rising prevalence of infertility cases has led to an increase in demand for ART treatment techniques. Furthermore, higher rate of successful pregnancies and births resulting from ART cycles using fresh nondonor eggs or embryos is expected to facilitate the market growth. For instance, in 2016, as per IVF birth rate statistics, around 6.5 million babies were born using in-vitro fertilization (IVF). Moreover, according to the Centers for Disease Control and Prevention (CDC), around 1.6 percent of babies born in the United States each year are conceived through assisted reproductive technology (ART).

ART cycles, are carried out using various procedures such as fresh donor, frozen donor, fresh nondonor, frozen nondonor and embryo/egg banking. The choice of procedures also affects growth of the assistive reproductive technology market, depending upon the type of technology procedures are also chosen. In 2015, according to Centers for Disease Control and Prevention (CDC) 26% fresh nondonor and 42% frozen nondonor procedures were performed in the U.S. These factors are expected to propel the global assistive reproductive technology market growth.

Restraints of the Global Assistive Reproductive Technology Market

One of the major restraints of this market is the issue of legal parental rights, and few concern of people such as, whose names will be there on birth certificate and who will have parental responsibility. Such factors may refrain parents to make use of assistive reproductive technologies.

Key features of the study

• This report provides in-depth analysis of the global assistive reproductive technology market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global assistive reproductive technology market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Cooper Surgical Inc., Hamilton Thorne, Inc., FUJIFILM Irvine Scientific, Inc., Merck KGaA, Nidacon International AB, Vitrolife AB, EMD Serono, Inc., INVO Bioscience, IVFtech ApS, Gonagen Medikal, Cook Medical Llc., and CellCura ASA
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global assistive reproductive technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the assistive reproductive technology market.

Market Segmentation

• By Product Type
  • Consumables
  • Instruments
• By Technology
  • In-vitro fertilization (IVF)
  • IVF with Intracytoplasmic Sperm Injection (ICSI)
  • IVF without Intracytoplasmic Sperm Injection (ICSI)
  • Artificial Insemination-Intrauterine Insemination (AI-IUI)
  • Frozen Embryo Replacement (FER)
  • Others
• By Procedures
  • Fresh Donor
  • Frozen Donor
  • Fresh Nondonor
  • Embryo/Egg Banking
  • Others
• By End User
  • Fertility Clinics
  • IVF Center
  • Hospital
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Assistive Reproductive Technology Market Key Players
  • Cooper Surgical Inc.
  • Hamilton Thorne, Inc.
  • FUJIFILM Irvine Scientific, Inc.
  • Merck KGaA
  • Nidacon International AB
  • Vitrolife AB
  • EMD Serono, Inc.
  • INVO Bioscience
  • IVFtech ApS
  • Gonagen Medikal
  • Cook Medical LLC.
  • CellCura ASA.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Technology
  • Market Snippet, By Procedure
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Novel Product Launch/Approval
• Acquisitions and Partnerships
• Technological Advancement
• Regulatory Scenario
• Reimbursement Scenario
• Product Recalls
• PEST Analysis
• PORTER's Analysis
• Epidemiology

4. Global Assistive Reproductive Technology Market, By Product Type, 2026 - 2033 (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026-2033
  • Segment Trends
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Segment Trends
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Segment Trends

5. Global Assistive Reproductive Technology Market, By Technology, 2026 - 2033 (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026-2033
  • Segment Trends
• In-vitro fertilization (IVF)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
    • IVF with Intracytoplasmic Sperm Injection (ICSI)
    • IVF without Intracytoplasmic Sperm Injection (ICSI)
• Artificial Insemination-Intrauterine Insemination (AI-IUI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Frozen Embryo Replacement (FER)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Assistive Reproductive Technology Market, By Procedures, 2026 - 2033 (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026-2033
  • Segment Trends
• Fresh Donor
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Frozen Donor
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Fresh Nondonor
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Embryo/Egg Banking
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Assistive Reproductive Technology Market, By End User, 2026 - 2033 (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026-2033
  • Segment Trends
• Fertility Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• IVF Center
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Hospital
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

8. Global Assistive Reproductive Technology Market, By Region, 2026 - 2033 (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2026-2033
• North America
  • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Procedure, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Region, 2026 - 2033 (USD Mn)
• U.S.
• Canada
• Europe
  • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Procedure, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Region, 2026 - 2033 (USD Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Procedure, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Region, 2026 - 2033 (USD Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Procedure, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Region, 2026 - 2033 (USD Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Africa
  • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Procedure, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Region, 2026 - 2033 (USD Mn)
• Central Africa
• South Africa
• North Africa
• Middle East
  • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Procedure, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Region, 2026 - 2033 (USD Mn)
• GCC
• Israel
• Rest of Middle East

9. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • Cooper Surgical Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hamilton Thorne, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FUJIFILM Irvine Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nidacon International AB
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vitrolife AB
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • EMD Serono, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • INVO Bioscience
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • IVFtech ApS
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Gonagen Medikal
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cook Medical LLC.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CellCura ASA
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

• References
• Research Methodology
• About us and Sales Contact